169 related articles for article (PubMed ID: 31994601)
1. Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways.
Zhao Z; Liu H; Guo D
Braz J Med Biol Res; 2020; 53(2):e8793. PubMed ID: 31994601
[TBL] [Abstract][Full Text] [Related]
2. Curcumin alleviates isoproterenol-induced cardiac hypertrophy and fibrosis through inhibition of autophagy and activation of mTOR.
Liu R; Zhang HB; Yang J; Wang JR; Liu JX; Li CL
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7500-7508. PubMed ID: 30468499
[TBL] [Abstract][Full Text] [Related]
3. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
[TBL] [Abstract][Full Text] [Related]
5. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
6. YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI
Wan M; Yin K; Yuan J; Ma S; Xu Q; Li D; Gao H; Gou X
J Ethnopharmacol; 2022 Mar; 285():114835. PubMed ID: 34798161
[TBL] [Abstract][Full Text] [Related]
7. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
[TBL] [Abstract][Full Text] [Related]
8. Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
Chen Y; Pan R; Zhang J; Liang T; Guo J; Sun T; Fu X; Wang L; Zhang L
J Ethnopharmacol; 2021 May; 272():113920. PubMed ID: 33607200
[TBL] [Abstract][Full Text] [Related]
9. Effect of aliskiren and carvedilol on expression of Ca(2+)/calmodulin-dependent protein kinase II δ-subunit isoforms in cardiac hypertrophy rat model.
Bin-Dayel AF; Abdel Baky NA; Fadda LM; Mohammad RA; Al-Mohanna F
Toxicol Mech Methods; 2016 Feb; 26(2):122-31. PubMed ID: 26982530
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-339-5p promotes isoproterenol-induced cardiomyocyte hypertrophy by targeting VCP to activate the mTOR signaling.
Bi X; Zhang Y; Yu Y; Yuan J; Xu S; Liu F; Ye J; Liu P
Cell Biol Int; 2022 Feb; 46(2):288-299. PubMed ID: 34854520
[TBL] [Abstract][Full Text] [Related]
12. Baicalin alleviates angiotensin II-induced cardiomyocyte apoptosis and autophagy and modulates the AMPK/mTOR pathway.
Cheng Y; Yan M; He S; Xie Y; Wei L; Xuan B; Shang Z; Wu M; Zheng H; Chen Y; Yuan M; Peng J; Shen A
J Cell Mol Med; 2024 May; 28(9):e18321. PubMed ID: 38712979
[TBL] [Abstract][Full Text] [Related]
13. KLF15 protects against isoproterenol-induced cardiac hypertrophy via regulation of cell death and inhibition of Akt/mTOR signaling.
Gao L; Guo Y; Liu X; Shang D; Du Y
Biochem Biophys Res Commun; 2017 May; 487(1):22-27. PubMed ID: 28336438
[TBL] [Abstract][Full Text] [Related]
14. Icariin inhibits isoproterenol-induced cardiomyocyte hypertropic injury through activating autophagy via the AMPK/mTOR signaling pathway.
Hu L; Wang Z; Li H; Wei J; Tang F; Wang Q; Wang J; Zhang X; Zhang Q
Biochem Biophys Res Commun; 2022 Feb; 593():65-72. PubMed ID: 35063771
[TBL] [Abstract][Full Text] [Related]
15. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
16. NLRC5 enhances autophagy via inactivation of AKT/mTOR pathway and ameliorates cardiac hypertrophy.
Ba B; Mayila A; Guo Y; Xu J; Xing S; Cao G
Int J Exp Pathol; 2022 Feb; 103(1):23-30. PubMed ID: 34802165
[TBL] [Abstract][Full Text] [Related]
17. Crude terpene glycoside component from Radix paeoniae rubra protects against isoproterenol-induced myocardial ischemic injury via activation of the PI3K/AKT/mTOR signaling pathway.
Ke Z; Wang G; Yang L; Qiu H; Wu H; Du M; Chen J; Song J; Jia X; Feng L
J Ethnopharmacol; 2017 Jul; 206():160-169. PubMed ID: 28549860
[TBL] [Abstract][Full Text] [Related]
18. Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy.
Huang K; Gao L; Yang M; Wang J; Wang Z; Wang L; Wang G; Li H
Int J Biochem Cell Biol; 2017 Aug; 89():6-15. PubMed ID: 28522343
[TBL] [Abstract][Full Text] [Related]
19. Chlorogenic acid attenuates cardiac hypertrophy via up-regulating Sphingosine-1-phosphate receptor1 to inhibit endoplasmic reticulum stress.
Ping P; Yang T; Ning C; Zhao Q; Zhao Y; Yang T; Gao Z; Fu S
ESC Heart Fail; 2024 Jun; 11(3):1580-1593. PubMed ID: 38369950
[TBL] [Abstract][Full Text] [Related]
20. Integrin β3 promotes cardiomyocyte proliferation and attenuates hypoxia-induced apoptosis via regulating the PTEN/Akt/mTOR and ERK1/2 pathways.
Wei L; Zhou Q; Tian H; Su Y; Fu GH; Sun T
Int J Biol Sci; 2020; 16(4):644-654. PubMed ID: 32025212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
